Oriental Securities Co., Ltd. (DFZQ) increased its holdings in Kelun-Biotech Biopharmaceutical (06990.HK) by 25,200 shares at approximately HK$490.76 per share.

Zhito Finance APP has learned that the latest data from the Hong Kong Stock Exchange shows that on September 22, Orient Securities Company Limited (DFZQ) increased its holdings in Kelun-Biotech (06990.HK) by 25,200 shares at HK$490.7615 per share, for a total amount of approximately HK$12.3672 million. After the increase, its latest shareholding was approximately 8.8446 million shares, with its latest shareholding ratio at 5.00%.